Miriam Benedicta (Louthan) Vos MD
Pediatric Hepatology and Liver Transplantation
Physician
Join to View Full Profile
1760 Haygood DrEmory University, Health Sciences Research BuildingAtlanta, GA 30322
Phone+1 404-727-9930
Dr. Vos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Louisville School of MedicineFellowship, Pediatric Gastroenterology, 2002 - 2005- University of Louisville School of MedicineResidency, Pediatrics, 1999 - 2002
- University of Louisville School of MedicineClass of 1999
Certifications & Licensure
GA State Medical License 2004 - 2025
IL State Medical License 2005 - 2008
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Clinical Trials
- Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis Start of enrollment: 2009 Jun 01
- Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders Start of enrollment: 2010 Dec 01
- Dietary Treatment Study of Pediatric NAFLD Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAddressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (...Zobair M Younossi, Homie Razavi, Michael Sherman, Alina M Allen, Quentin M Anstee
Alimentary Pharmacology & Therapeutics. 2025-02-18 - Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.Dunia Hatabah, Sneh Lata Gupta, Grace Mantus, Patrick Sullivan, Stacy Heilman
Vaccines. 2025-02-07 - Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associ...Kimberly P Newton, Dulshan Jayasekera, Amanda L Blackford, Cynthia Behling, Laura A Wilson
Hepatology. 2025-01-03
Journal Articles
- Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLDMiriam B Vos, Craig J McClain, MDPI
- A Randomized, Controlled, Crossover Pilot Study of Losartan for Pediatric Nonalcoholic Fatty Liver DiseaseSaul Karpen, Jennifer K Frediani, Miriam B Vos, BioMed Central
Press Mentions
New Target RWE Research Validates Updated Liver Disease Terminology in ChildrenNovember 25th, 2024
This Is Your Body on SugarOctober 30th, 2024- Large Real-World Study Uncovers Higher Prevalence of Non-Alcoholic Fatty Liver Disease Markers, Liver Biopsy, and Cirrhosis in ChildrenMarch 29th, 2022
- Join now to see all
Grant Support
- Patient-Oriented Research for Cardiometabolic Health in ChildrenEMORY UNIVERSITY2024–2029
- Prevention of Pediatric NAFLD in Hispanic ChildrenEMORY UNIVERSITY2021–2026
- Prevention of Pediatric NAFLD in Hispanic ChildrenEMORY UNIVERSITY2021–2026
- Dietary Fructose And Redox Effects In Pediatric Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
